Inactive Instrument

Analyst Reco. Tokai Pharmaceuticals Inc Nasdaq

Equities

Noble Capital Initiates Coverage on Eledon Pharmaceuticals with Outperform Rating, $10 Price Target	23-09-27	MT
SVB Securities LLC Adjusts Price Target for Eledon Pharmaceuticals to $26 From $33, Reiterates Outperform Rating	22-06-01	MT
HC Wainwright Adjusts Eledon Pharmaceuticals' Price Target to $25 From $35, Keeps Buy Rating	21-11-24	MT
ELEDON PHARMACEUTICALS : SVB Leerink Adjusts Price Target on Eledon Pharmaceuticals to $33 From $34, Maintains Outperform Rating	21-04-27	MT
ELEDON PHARMACEUTICALS : Cantor Fitzgerald Starts Eledon Pharmaceuticals at Overweight With $25 Price Target	21-03-23	MT
ELEDON PHARMACEUTICALS : SVB Leerink Starts Eledon Pharmaceuticals at Outperform With $34 Price Target	21-02-08	MT

No results for this search